Combination of the peptide epoxyketone proteasome inhibitor carfilzomib with melphalan for use in the treatment of cancer

摘要

The invention provides combination therapy, wherein one or more other therapeutic agents are administered agents are administered with peptide epoxyketones or a pharmaceutically acceptable salt thereof. Another aspect of the invention relates to treating cancer with a peptide epoxyketone administered in combination with another therapeutic agent.